Yoshimitsu Minari

Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.

Ken Uegaki, Nio Y, Yoshiyuki Inoue et al. · PubMed · 1998 · 95 citations

Medicine, Oncology, Pathology +17

p53 protein expression as prognostic factor in human pancreatic cancer.

Yoshitoshi Sato, Nio Y, Song Mm et al. · PubMed · 1997 · 38 citations

Medicine, Oncology, Pathology +17

Comparative Significance of p53 and WAF/l-p2 1 Expression on the Efficacy of Adjuvant Chemotherapy for Resectable Invasive Ductal Carcinoma of the Pancreas

Yoshinori Nio, Ming Dong, Ken Uegaki et al. · Pancreas · 1999 · 28 citations

Medicine, Cancer Biology, Oncology +16

Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.

Y Nio, Noriyuki Hirahara, Yoshimitsu Minari et al. · PubMed · 2000 · 28 citations

Medicine, Oncology, Pharmacology +15

A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines

Yoshinori Nio, Hiroshi Ohmori, Yoshimitsu Minari et al. · Anti-Cancer Drugs · 1997 · 17 citations

Medicine, Oncology, Pharmacology +11